RYAN LUECK: Open Payments
NPI 1871041566 · SPRINGFIELD, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$606 in 28 payments from 12 companies in 2025. Trend: 2023 $1,235 · 2024 $1,797 · 2025 $606
Food & beverage: $606
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 6 | $120 |
| PFIZER INC. | 6 | $114 |
| Novartis Pharmaceuticals Corporation | 3 | $80 |
| Solventum Corporation | 1 | $48 |
| JAZZ PHARMACEUTICALS INC. | 2 | $47 |
| ARGENX US, INC. | 2 | $45 |
| EMD Serono, Inc. | 2 | $40 |
| Eisai Inc. | 2 | $33 |
| UCB, Inc. | 1 | $27 |
| Otsuka America Pharmaceutical, Inc. | 1 | $20 |
Products named: NURTEC ODT, KESIMPTA, V.A.C. VERAFLO CLEANSE CHOICE, EPIDIOLEX, QULIPTA, VYVGART HYTRULO, UBRELVY, BOTOX.
Industry payments across MO — which companies pay providers there.
